Article
Change On The Horizon For Biomanufacturing
January 26, 2012
By Eric Langer, president and managing partner, BioPlan Associates, Inc.
A leading indicator as to where the global bio industry is headed, geographically, is where its global vendors are setting up shop. In our 8th Annual Report and Survey of Biopharmaceutical Manufacturing, along with 352 biomanufacturers, we also surveyed 186 suppliers to the industry.
This year, more than half of the industry's suppliers are actively selling products and services in both China and India (51.2% each). The percentage is up from just three years ago when 38.7% of vendors were actively selling in India and 37.7% in China. This mirrors the global optimism associated with these large markets. It also suggests that vendors recognize the strategic importance of establishing a presence within domestic foreign markets. We also found this year that there is modest growth in the percentage of suppliers selling to these geographies: South America (41.1%), the Middle East (36.7%), and Central America (35.7%).
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get exclusive access to this piece of content and thousands of addtional articles and product reviews across our entire network of sites.
